Mar 2019 | Archives
Guests at the Recent Oscars Lunch glammed up to enjoy the broadcast of the 91st Oscars in style. Guests included the Today Show team, participants in Married at First Site, Doctor Doctor cast members and many more.
Hosted By Channel 9 at Glass Brasserie, guests were treaded to a sumptuous 3 course lunch by Luke Mangan and the team at glass brasserie.
While watching all the events unfold from LA, guests were entertained by Host Tom Steinfort as well as vying for the amazing raffle items which including a 9 litre bottle of Louis Roederer.
Funds raised from the day, a total of almost $40k, will help Cure The Future to fund fund equipment, services and the professional development of Professor John Rasko’s inspirational team of scientists and researchers to enhance their ground breaking work, to have a greater impact now and for generations to come.
Thank you to our major sponsors Volvo, Channel 9, glass brasserie, The Luke Mangan Group for making the event possible.
Thanks also goes to those who supported the event with raffle prizes or products for the event goodie bag, including:
Clinique, Harvey Norman, Kemenys, Sofi Spritz, CharGrill Charlies, Lady Jane, Sparkling White Smile, Warner Bros, Stage and Screen, Pierre Haddad, Flawless Rejuvenation, Liquefy, Coca Cola, Candice PR, DeLorenzo, Sebamed, Zeka Manfred, Slim Secrets, Long Lashes, Taprobane Tea Company, Maine Beach, Skyzone, Holey Moley, Strike Bowling, B x Earth, Veraision Wines, Calabria, The Healthy Chef, Shannakin Fine Jewellery, Loreal, Argyle Inn Taralga, Netball NSW, GlamCorner, Hush Puppies, Universal Pictures, Universal Music.
Watch the highlights of the event.
Mar 2019 | Archives
The Australian Academy of Science have announced their latest awards for outstanding contributions to science with 20 of Australia’s leading scientists receiving a 2019 honorific award.
Dr Justin Wong, a past recipient of a Cure The Future Fellowship has been recognised for his work in gene expression and its applications in cancer therapies having been awarded the 2019 Ruth Stephens Gani Medal.
Watch the Video About the Award
<iframe width="560" height="315" src="https://www.youtube.com/embed/gDvjJOG7k7A" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
Dr Wong, then a research officer, received the inaugural Cure The Future Fellowship which provided salary support for 18 months.
Support from Cure The Future has provided Dr.Wong the ability to embark on a project to discover novel mechanisms that regulates gene expression in normal and cancer cells. Over the past 9 years, since receiving the Cure The Future Fellowship, Dr Wong has made many journal contributions and research breakthroughs have resulted in over $5 million dollars in grant funding for more research to find ways to combat cancers.
Every junior researcher requires start up funding to achieve scientific excellence. I am forever grateful to Cure The Future for providing this in the first 2 years of my postdoctoral research. I am a living testimony that Cure The Future contributes towards building the career of a young researcher like myself. Justin Wong
Since receiving the Cure The Future support, Dr. Wong has progressed on to become an independent laboratory head at the Centenary Institute focusing on understanding mechanisms that regulate gene expression and how mistakes in these processes cause cancers.
Congratulations from Cure The Future.
Do you want to help more researchers like Justin?
Your support could help cure the future of thousands of Australians.
Dec 2018 | Archives
Cure the Future Service Awards Announced
The Cure the Future Service Awards where announced recently at the end of year party for both the clinical and research teams of Professor John Rasko AO.
The teams from the Centenary Institute and Department of Cell and Molecular Therapies, enjoyed a well deserved afternoon of relaxation and reflection after a big year of successful grant applications and commencement of ground breaking clinical trials.
The Awards are given to one staff member in each on the teams who have demonstrated excellence throughout the year. The winners of the awards for 2018 were:
Dr Carl Power for excellence in pursuing ethical questions and raising public awareness in the field of Gene and Stem Cell Therapy, in particular for support with the preparations for the ABC Boyer lectures.
Dr Zlatibor Velickovik for excellence in pursuing and developing philanthropic and government sponsored research grants, resulting in several successful grants supporting clinical trials.
Both recipients are pictured below with Cure the Future representatives.
Cure the Future Service Award Presentation – Dianne Langmack OAM(Chair), Professor John Rasko AO, Dr Carl Power (recipient), Jennifer Andrews(Vice Chair), Dr Zlatibor Velickovik (recipient)
Dec 2018 | Archives
Congratulations to Professor John Rasko and his team, who have recently been recognised for their excellent in research and clinical work with funding from the Li Ka Shing Foundation, for a world-first immunotherapy trial for patients with mesothelioma and pancreatic cancer.
The Li Ka Shing Foundation has funded the newly established Li Ka Shing Cell and Gene Therapy Initiative at the University of Sydney to the tune of $4.5 million over 4 years.
The funding will enable clinical trials on both patients with mesothelioma and pancreatic cancer. The trials will involve the reprogramming of CAR T cells, healthy immune cells, which will be reproduced and re injected into to patients to fight and destroy cancer cells. The impact of this technology is profound on participants in the clinical trials.
About CAR T Research
Early clinical data from leading research centres around the World highlights the promise of Chimeric Antigen Receptor (CAR) T cells for the targeted treatment of cancers such as pancreatic cancer, muscle cancer, ovarian cancer, some breast cancers and asbestos-related lung cancer.
A collaboration of international researchers agree it is the best possible promise of a cure we have seen – so they have got together to do clinical trials of this treatment. Australia’s team, led by Professor John Rasko, Australia’s leading Cell & Molecular Therapies specialist, will leverage the existing cell manufacturing infrastructure and expertise at the Cell & Molecular Therapies department at Royal Prince Alfred Hospital.
International collaborators will work together to develop these CAR-T cells – and initiate Phase I clinical trials to treat each of these cancer conditions.
In Australia, the initial focus will be on the treatment of advanced pancreatic cancer. This treatment option will be a first for Australian patients – and cellular immunotherapy of the type proposed here may revolutionise outcomes for patients and their families living with many types of cancer.
Our “CAR-T mesothelin” cancer immunotherapy is potentially capable of targeting pancreatic, ovarian, synovial and mesothelioma (a subset of lung cancer caused by exposure to asbestos) and well as other lung cancer & breast cancer subsets.
Watch the video to learn more about Car T Research
About Cure the Future
Cure The Future’s mission is to support and enhance the research and clinical work of Professor John Rasko and his team. We are proud support the promotion this initiative.
